+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Respiratory Disease Testing Market Research Report by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4985882
  • Report
  • July 2021
  • Region: Global
  • 191 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Respiratory Disease Testing Market will Grow to USD 4,643.28 Million by 2026, at a CAGR of 4.24%

FEATURED COMPANIES

  • Abbott Laboratories
  • Biomérieux
  • Carestream Medical
  • Fujifilm Holdings
  • Koninklijke Philips N.V
  • ResMed
The Global Respiratory Disease Testing Market size was estimated at USD 3,617.87 Million in 2020 and expected to reach USD 3,759.27 Million in 2021, at a Compound Annual Growth Rate (CAGR) 4.24% to reach USD 4,643.28 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Respiratory Disease Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on End-User, the Respiratory Disease Testing Market was studied across Clinical Laboratories and Hospitals.
  • Based on Product, the Respiratory Disease Testing Market was studied across Blood Gas Test, Imaging Tests, and Respiratory Measurement.
  • Based on Region, the Respiratory Disease Testing Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Respiratory Disease Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Respiratory Disease Testing Market, including Abbott Laboratories, Alere Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomérieux, CareFusion Corporation, Carestream Medical, Cosmed, Fisher & Paykel Healthcare Limited, Fujifilm Holdings, GE Healthcare, Hitachi Medical Corporation, Koninklijke Philips N.V, Medtronic Plc, MGC Diagnostics Corporation, ResMed, Sdi Diagnostics, Seegene Inc., SELUTEC GmbH, Shimadzu Corporation, Siemens Healthcare, Thermo Fisher Scientific Inc., and Toshiba Medical Systems Corporation.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Respiratory Disease Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Respiratory Disease Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Respiratory Disease Testing Market?
4. What is the competitive strategic window for opportunities in the Global Respiratory Disease Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Respiratory Disease Testing Market?
6. What is the market share of the leading vendors in the Global Respiratory Disease Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Respiratory Disease Testing Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Biomérieux
  • Carestream Medical
  • Fujifilm Holdings
  • Koninklijke Philips N.V
  • ResMed
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. End-User Outlook
3.4. Product Outlook
3.5. Region Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of respiratory diseases
5.1.1.2. Adoption of unhealthy lifestyle and habits such as tobacco smoking
5.1.1.3. Constantly rising air pollution levels
5.1.1.4. Major adoption of imaging technology for diagnostics
5.1.2. Restraints
5.1.2.1. Availability of alternatives systems and devices
5.1.3. Opportunities
5.1.3.1. Rising preferences for remote or home care testing devices
5.1.3.2. R&D and technology advancements in testing methods for effective, efficient, and faster results
5.1.4. Challenges
5.1.4.1. Lack of supportive reimbursement policies
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Respiratory Disease Testing Market, by End-User
6.1. Introduction
6.2. Clinical Laboratories
6.3. Hospitals

7. Respiratory Disease Testing Market, by Product
7.1. Introduction
7.2. Blood Gas Test
7.3. Imaging Tests
7.4. Respiratory Measurement

8. Americas Respiratory Disease Testing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Respiratory Disease Testing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Thailand

10. Europe, Middle East & Africa Respiratory Disease Testing Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbott Laboratories
12.2. Alere Inc.
12.3. Becton, Dickinson and Company
12.4. Bio-Rad Laboratories, Inc.
12.5. Biomérieux
12.6. CareFusion Corporation
12.7. Carestream Medical
12.8. Cosmed
12.9. Fisher & Paykel Healthcare Limited
12.10. Fujifilm Holdings
12.11. GE Healthcare
12.12. Hitachi Medical Corporation
12.13. Koninklijke Philips N.V
12.14. Medtronic Plc
12.15. MGC Diagnostics Corporation
12.16. ResMed
12.17. Sdi Diagnostics
12.18. Seegene Inc.
12.19. SELUTEC GmbH
12.20. Shimadzu Corporation
12.21. Siemens Healthcare
12.22. Thermo Fisher Scientific Inc.
12.23. Toshiba Medical Systems Corporation

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2020 (USD MILLION)
FIGURE 3. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 4. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 5. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 6. GLOBAL RESPIRATORY DISEASE TESTING MARKET: MARKET DYNAMICS
FIGURE 7. GLOBAL RESPIRATORY DISEASE TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 8. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
FIGURE 9. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2026
FIGURE 11. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 16. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2026
FIGURE 18. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY BLOOD GAS TEST, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY BLOOD GAS TEST, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY IMAGING TESTS, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY IMAGING TESTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY RESPIRATORY MEASUREMENT, 2018-2026 (USD MILLION)
FIGURE 23. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY RESPIRATORY MEASUREMENT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 24. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 25. ARGENTINA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 26. BRAZIL RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 27. CANADA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 28. MEXICO RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 29. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 30. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 31. AUSTRALIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 32. CHINA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 33. INDIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 34. INDONESIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 35. JAPAN RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 36. MALAYSIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 37. PHILIPPINES RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 38. SINGAPORE RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. SOUTH KOREA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. THAILAND RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. FRANCE RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. GERMANY RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. ITALY RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. NETHERLANDS RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. QATAR RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. RUSSIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. SAUDI ARABIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. SOUTH AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. SPAIN RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. UNITED ARAB EMIRATES RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. UNITED KINGDOM RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. GLOBAL RESPIRATORY DISEASE TESTING MARKET: FPNV POSITIONING MATRIX
FIGURE 54. GLOBAL RESPIRATORY DISEASE TESTING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 55. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL RESPIRATORY DISEASE TESTING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY BLOOD GAS TEST, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY RESPIRATORY MEASUREMENT, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 12. ARGENTINA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 13. BRAZIL RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 14. CANADA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 15. MEXICO RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 17. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 18. AUSTRALIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 19. CHINA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. INDIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. INDONESIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. JAPAN RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. MALAYSIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. PHILIPPINES RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. SINGAPORE RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. SOUTH KOREA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. THAILAND RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. FRANCE RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. GERMANY RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. ITALY RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. NETHERLANDS RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. QATAR RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. RUSSIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. SAUDI ARABIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. SOUTH AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. SPAIN RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. UNITED ARAB EMIRATES RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. UNITED KINGDOM RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. GLOBAL RESPIRATORY DISEASE TESTING MARKET: SCORES
TABLE 41. GLOBAL RESPIRATORY DISEASE TESTING MARKET: BUSINESS STRATEGY
TABLE 42. GLOBAL RESPIRATORY DISEASE TESTING MARKET: PRODUCT SATISFACTION
TABLE 43. GLOBAL RESPIRATORY DISEASE TESTING MARKET: RANKING
TABLE 44. GLOBAL RESPIRATORY DISEASE TESTING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 45. GLOBAL RESPIRATORY DISEASE TESTING MARKET: MERGER & ACQUISITION
TABLE 46. GLOBAL RESPIRATORY DISEASE TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 47. GLOBAL RESPIRATORY DISEASE TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 48. GLOBAL RESPIRATORY DISEASE TESTING MARKET: INVESTMENT & FUNDING
TABLE 49. GLOBAL RESPIRATORY DISEASE TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 50. GLOBAL RESPIRATORY DISEASE TESTING MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Alere Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomérieux
  • CareFusion Corporation
  • Carestream Medical
  • Cosmed
  • Fisher & Paykel Healthcare Limited
  • Fujifilm Holdings
  • GE Healthcare
  • Hitachi Medical Corporation
  • Koninklijke Philips N.V
  • Medtronic Plc
  • MGC Diagnostics Corporation
  • ResMed
  • Sdi Diagnostics
  • Seegene Inc.
  • SELUTEC GmbH
  • Shimadzu Corporation
  • Siemens Healthcare
  • Thermo Fisher Scientific Inc.
  • Toshiba Medical Systems Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll